Latest available resultsQuarter ended June 30, 202610-Q · August 5, 2026
Filed with the SECALIGN TECHNOLOGY INC
ALGNHealthcare
Next reportOctober 28, 2026after close · Analyst forecast 2.857 $/share
Revenue
$1.06B
▲ +4.3% vs prior year% YoY
Net income
$108.29M
▼ -13.1% vs prior year% YoY
EPS
1.51$
▼ -12.2% vs prior year% YoY
Net margin
10.3%
▼ -2.1 percentage points vs prior year pp YoY
Revenue▲ +4.3 %
Margins (% of revenue)GrossOperatingNet
Net income▼ -13.1 %
EPS▼ -12.2 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $1.06B | |
| Gross profit | $757.43M | 71.7 % |
| Operating income | $154.01M | 14.6 % |
| Net income | $108.29M | 10.3 % |
| R&D | $102.03M | 9.7 % |
| EPS (diluted) | 1.51 $ | |
| Balance sheet | ||
| Assets | $6.42B | |
| Liabilities | $2.19B | |
| Equity | $4.23B | |
| Cash | $1.10B | |
| Capital | ||
| Shares outstanding | 71.04M | as of 2026-07-31 |
| Public float | — | |